DNLI logo

Denali Therapeutics (DNLI) Current Assets

Annual Current Assets

$864.44 M
-$199.70 M-18.77%

December 31, 2024


Summary


Performance

DNLI Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIbalance sheetmetrics:

Quarterly Current Assets

$864.44 M
-$4.40 M-0.51%

December 31, 2024


Summary


Performance

DNLI Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

DNLI Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.8%0.0%
3 y3 years-3.7%0.0%
5 y5 years+101.0%0.0%

DNLI Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-37.0%at low-37.0%at low
5 y5-year-42.2%+101.0%-42.2%+101.0%
alltimeall time-42.2%+2485.7%-42.2%+375.1%

Denali Therapeutics Current Assets History

DateAnnualQuarterly
Dec 2024
$509.74 M(+467.8%)
$864.44 M(-0.5%)
Sep 2024
-
$868.84 M(-6.4%)
Jun 2024
-
$928.38 M(-4.6%)
Mar 2024
-
$973.58 M(-8.5%)
Dec 2023
$89.78 M(+2.1%)
$1.06 B(-6.9%)
Sep 2023
-
$1.14 B(-6.6%)
Jun 2023
-
$1.22 B(-7.6%)
Mar 2023
-
$1.33 B(-3.4%)
Dec 2022
$87.92 M(-82.7%)
$1.37 B(+20.5%)
Sep 2022
-
$1.14 B(+2.1%)
Jun 2022
-
$1.11 B(+12.8%)
Mar 2022
-
$988.44 M(+10.2%)
Dec 2021
$506.93 M(+366.7%)
$897.23 M(-15.0%)
Sep 2021
-
$1.06 B(-21.3%)
Jun 2021
-
$1.34 B(-6.3%)
Mar 2021
-
$1.43 B(-4.3%)
DateAnnualQuarterly
Dec 2020
$108.63 M(-11.8%)
$1.50 B(+54.1%)
Sep 2020
-
$970.87 M(+73.6%)
Jun 2020
-
$559.41 M(-7.5%)
Mar 2020
-
$604.78 M(+40.6%)
Dec 2019
$123.20 M(-32.0%)
$430.03 M(-13.0%)
Sep 2019
-
$494.38 M(-0.3%)
Jun 2019
-
$495.98 M(-0.7%)
Mar 2019
-
$499.53 M(+3.9%)
Dec 2018
$181.15 M(+134.9%)
$480.84 M(+25.4%)
Sep 2018
-
$383.40 M(+1.6%)
Jun 2018
-
$377.42 M(-0.0%)
Mar 2018
-
$377.42 M(-7.9%)
Dec 2017
$77.11 M(-13.5%)
$409.61 M(+117.6%)
Sep 2017
-
$188.24 M(+3.5%)
Dec 2016
$89.11 M(+2640.2%)
$181.96 M
Dec 2015
$3.25 M
-

FAQ

  • What is Denali Therapeutics annual total current assets?
  • What is the all time high annual current assets for Denali Therapeutics?
  • What is Denali Therapeutics annual current assets year-on-year change?
  • What is Denali Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Denali Therapeutics?
  • What is Denali Therapeutics quarterly current assets year-on-year change?

What is Denali Therapeutics annual total current assets?

The current annual current assets of DNLI is $864.44 M

What is the all time high annual current assets for Denali Therapeutics?

Denali Therapeutics all-time high annual total current assets is $1.50 B

What is Denali Therapeutics annual current assets year-on-year change?

Over the past year, DNLI annual total current assets has changed by -$199.70 M (-18.77%)

What is Denali Therapeutics quarterly total current assets?

The current quarterly current assets of DNLI is $864.44 M

What is the all time high quarterly current assets for Denali Therapeutics?

Denali Therapeutics all-time high quarterly total current assets is $1.50 B

What is Denali Therapeutics quarterly current assets year-on-year change?

Over the past year, DNLI quarterly total current assets has changed by $0.00 (0.00%)